You seem to have a good eye for the 'diamond in the rough' penny stock. On advice from a friend in the health care industry, I've been buying UPBS steadly for the past 2 mos. This is an excellent opportunity.
As far as TKO, I don't get the level of negativity despite the apparent dilution. The guidance isn't spectacular but is positive and does show diversity in the business model as well as cash flow positive forecast. This should be enough to stabilize the stock.Don't quite understand why it isn't. Like Serius, I suspect we're missing some aspect of TKO that is alarming and/or significantly negative.